Citius buys Leonard Meron
One month after signing a letter of intent, specialty pharmaco Citius Pharmaceuticals Inc. finalized its acquisition of private company Leonard Meron Biosciences Inc. (LMB; anti-infectives).
- Acquisition of Private Biotech
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.